Kala Bio (KALA) Net Equity Issued and Repurchased (2017 - 2026)
Kala Bio's Net Equity Issued and Repurchased was $4.1 million in Q1 2026, compared with $13,000 a year earlier and down 55.1% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Net Equity Issued and Repurchased (2017 - 2026) Analysis & Trends
For FY2025, Net Equity Issued and Repurchased at Kala Bio came in at $11.01 million, down 8.3% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -41.5% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $12.01 million in FY2024 (-41.6%), $20.55 million in FY2023, $1.34 million in FY2022 (-96.9%) and $42.82 million in FY2021 (-73.3%).
- Quarterly Net Equity Issued and Repurchased has moved between -$2.47 million (Q2 2024) and $14.9 million (Q1 2023) over five years.
- Compared with a year earlier, Net Equity Issued and Repurchased was higher in two of the last four quarters, with growth averaging 188.2%.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q4 2025 (growth of 889.6%); the worst was Q1 2025 (a decline of 99.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | - |
| 10 | Kala Bio | 2.38 Mn | -42.27 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 4.10 Mn |
| Dec 31, 2025 | 9.13 Mn |
| Sep 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 923,000.00 |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | -2.47 Mn |
| Mar 31, 2024 | 8.56 Mn |
| Dec 31, 2023 | 570,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Jun 30, 2023 | 3.07 Mn |
| Mar 31, 2023 | 14.90 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 138,000.00 |
| Mar 31, 2022 | 163,000.00 |
| Dec 31, 2021 | 169,000.00 |
| Sep 30, 2021 | 1.24 Mn |
| Jun 30, 2021 | 6.09 Mn |
| Mar 31, 2021 | 35.32 Mn |
| Dec 31, 2020 | 20.73 Mn |
API Access
Kala Bio Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();